儿童心力衰竭的研究差距:定义差距,然后在未来十年内将其缩小
Shahnawaz Amdani1, Scott R Auerbach2, Neha Bansal3
1Department of Pediatric Cardiology, Cleveland Clinic Children's, Cleveland, Ohio.
Journal of cardiac failure
|December 8, 2023
概括
儿科心力衰竭研究有很多机会,但存在知识差距. 专家们确定了科学家和资助者在未来十年中优先考虑的关键领域.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管研究研究心血管研究
- 翻译医学是一种翻译医学.
背景情况:
- 儿科心力衰竭 (PHF) 提供了重要的研究机会.
- 实质性的知识差距阻碍了理解和治疗PHF的进展.
- 一个协调的研究议程对于推动该领域的发展至关重要.
研究的目的:
- 确定儿科心力衰竭的关键研究缺口.
- 引导未来的科学调查和资金优先事项.
- 为PHF建立一个为期10年的研究路线图.
主要方法:
- 召集了一个由儿科心力衰竭专家组成的国际多学科小组.
- 进行了建立共识的过程,以确定研究重点.
- 综合了PHF各个领域的专家意见.
主要成果:
- 在所有主要的儿科心力衰竭领域确定了特定的知识差距.
- 突出领域需要紧急的科学研究和资金.
- 建立了对未来十年最紧迫的研究需求的共识.
结论:
- 解决发现的研究缺口对于推进儿科心力衰竭护理至关重要.
- 要克服当前的局限性,需要一个专注的,协作的研究努力.
- 概述的优先事项将指导未来的PHF研究和资金.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436


